A Novel Allele of Myosin VIIa Reveals a Critical Function for the C-Terminal FERM Domain for Melanosome Transport in Retinal Pigment Epithelial Cells by Schwander, M. et al.
Neurobiology of Disease
A Novel Allele of Myosin VIIa Reveals a Critical Function for
the C-Terminal FERM Domain for Melanosome Transport in
Retinal Pigment Epithelial Cells
Martin Schwander,1 Vanda Lopes,2,3 Anna Sczaniecka,1 Daniel Gibbs,2 Concepcion Lillo,2 David Delano,4
Lisa M. Tarantino,5 Tim Wiltshire,5 David S. Williams,2,3 and Ulrich Müller1
1Department of Cell Biology, Institute for Childhood and Neglected Disease, The Scripps Research Institute, La Jolla, California 92037, 2Departments of
Pharmacology and Neuroscience, School of Medicine, University of California at San Diego, La Jolla, California 92093, 3Departments of Ophthalmology and
Neurobiology, Jules Stein Eye Institute, School of Medicine, University of California Los Angeles, Los Angeles, California 90095, 4Genomics Institute of the
Novartis Research Foundation, San Diego, California 92121, and 5Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina 27516
Mutations in the head and tail domains of the motor protein myosin VIIA (MYO7A) cause deaf-blindness (Usher syndrome type 1B,
USH1B) and nonsyndromic deafness (DFNB2, DFNA11). The head domain binds to F-actin and serves as the MYO7A motor domain, but
little is known about the function of the tail domain. In a genetic screen, we have identified polka mice, which carry a mutation (c.5742 
5G  A) that affects splicing of the MYO7A transcript and truncates the MYO7A tail domain at the C-terminal FERM domain. In the inner
ear, expression of the truncated MYO7A protein is severely reduced, leading to defects in hair cell development. In retinal pigment
epithelial (RPE) cells, the truncated MYO7A protein is expressed at comparative levels to wild-type protein but fails to associate with and
transport melanosomes. We conclude that the C-terminal FERM domain of MYO7A is critical for melanosome transport in RPE cells. Our
findings also suggest that MYO7A mutations can lead to tissue-specific effects on protein levels, which may explain why some mutations
in MYO7A lead to deafness without retinal impairment.
Introduction
MYO7A consists of an N-terminal motor domain followed by
a neck and tail domain (Chen et al., 1996). The motor domain
enables movement of MYO7A on actin filaments. The tail
domain interacts with vesicle-associated proteins such as
Slac2-c/MyRIP suggesting that MYO7A might play a role in
cargo transport (Kuroda and Fukuda, 2005; Soni et al., 2005;
Klomp et al., 2007). Over 100 mutations have been identified
in MYO7A that affect the head and tail domains and cause
syndromic (USH1B) and nonsyndromic (DFNB2, DFNA11)
deafness (http://www.hgmd.cf.ac.uk/ac/gene.php?geneMYO7A).
Mutations in the head domain are thought to affect MYO7A
motor function, but little is known about the mechanisms by
which mutations in the tail domain affect protein function.
Studies in mice have provided insights into the cellular mech-
anisms by which mutations in MYO7A cause disease. Myo7a mu-
tations in shaker-1 mice cause recessive deafness, vestibular
dysfunction, and retinal abnormalities (Gibson et al., 1995; Liu et
al., 1997). In the inner ear, MYO7A is expressed in mechanosen-
sory hair cells and is required for hair bundle morphogenesis and
mechanotransduction (Self et al., 1998; Kros et al., 2002). Within
the retina, MYO7A localizes to the cilium of the photoreceptors,
to the apical region of retinal pigment epithelial (RPE) cells, and
to melanosomes within RPE cells (Wolfrum et al., 1998; El-
Amraoui et al., 2002; Gibbs et al., 2004). In accordance with its
expression pattern, MYO7A regulates opsin transport in pho-
toreceptors and the phagocytosis of shed outer segments by
RPEs (Liu et al., 1999; Gibbs et al., 2003). Melanosomes fail to
localize to the apical processes in RPEs of shaker-1 mice, indi-
cating that MYO7A is required for movement and/or reten-
tion of melanosomes within the apical processes (Liu et al.,
1998). Unlike the human patients, shaker-1 mice do not show
degeneration of photoreceptor cells, suggesting that the mice
mimic only some aspects of the human disease. Nevertheless,
mice provide currently the best available animal model for the
human disease.
Here, we report a novel Myo7a allele termed polka that we
isolated in a genetic screen in mice (Schwander et al., 2007). Polka
mice carry a point mutation (c.5742  5G  A) in intron 42 that
affects splicing and is predicted to truncate the tail domain of
MYO7A at its C-terminal FERM domain. While the mutant
MYO7A protein was expressed in the retina, little expression was
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observed in the inner ear. Hair bundles in the inner ear showed
morphological defects that likely caused the deafness phenotype
of polka mice. In the retina, the mutant MYO7A protein was still
localized to the apical processes of RPE cells, but associated less
well with melanosomes, which were mislocalized. We conclude
that the C-terminal FERM domain of MYO7A is important for
association with and transport of melanosomes. In addition, our
findings show that a point mutation in a gene can differentially
affect its expression in the inner ear and retina, a finding that
might be relevant to understanding disease mechanisms associ-
ated with mutations in Myo7a.
Materials and Methods
ENU mutagenesis screen and evaluation of inner ear function. The ENU
mutagenesis protocol and primary phenotypic screen has been de-
scribed previously (Reijmers et al., 2006; Schwander et al., 2007). The
measurement of auditory brainstem responses (ABRs), distortion prod-
uct otoacoustic emissions (DPOAEs), and vestibular function followed
our published procedures (Schwander et al., 2007).
Linkage analysis and DNA sequencing. Linkage analysis using single nu-
cleotide polymorphism (SNP) markers was performed as described pre-
viously (Wiltshire et al., 2003; Schwander et al., 2007). Affected polka
mice were bred with 129S1/SvImJ mice. The F1 offspring were inter-
crossed to obtain F2 mice and tail DNA was prepared for linkage mapping
using SNPs markers (Wiltshire et al., 2003). Map Manager QTX (Manly
et al., 2001) was used to calculate logarithm of the odds (LOD) scores and
perform interval mapping. Exons and exon–intron boundaries of genes
in the mapped intervals were sequenced. Primers for PCR amplification
and DNA sequencing were designed with Primer 3 software (MIT). DNA
numbering is based on Myo7a cDNA
(NM_008663) and starts with 1 as the A of
the ATG initiation methionine.
Histology, immunohistochemistry, and scan-
ning electron microscopy. Staining of sections
and TUNEL staining were performed as de-
scribed previously (Fariñas et al., 1996; Müller
et al., 1997; Gibbs et al., 2004). Whole-mount
staining and scanning electron microscopy of
cochlear sensory epithelia were performed as
described previously (Senften et al., 2006;
Schwander et al., 2007).
Immunoelectron microscopy and gold particle
quantitation. For immunoelectron microscopy,
eyecups were fixed by immersion in 0.25% glu-
taraldehyde, 4% paraformaldehyde in 0.1 M ca-
codylate buffer, pH 7.4. Samples were
embedded in LR White (EMS). Ultrathin sec-
tions (70 m) were etched with saturated so-
dium periodate and blocked with 4% bovine
serum albumin (BSA) in antibody buffer (1%
BSA  1% Tween 20) for 1 h. The sections were
then incubated with primary antibodies (anti-
MYO7A and anti-MYRIP) overnight at 4°C.
After washing, samples were incubated with
goat anti-rabbit IgG conjugated to 12 nm gold
(EMS) for 1 h. Finally sections were stained
with uranyl acetate and lead citrate. Sections
that were not incubated with the primary anti-
body or shaker-1 sections (sh14626SB) (Rinchik
and Carpenter, 1999) were processed at the
same time and used as negative controls. Im-
munolabeling density was determined by
counting gold particles in ultrathin sections.
Images were taken randomly along the RPE, 25
per condition, and analyzed. Gold particles
were considered to be associated with the mela-
nosome membrane when located at a maxi-
mum of 30 nm of the membrane of the
organelle, as described previously (Klomp et
al., 2007). Section area was determined with ImageJ software.
Complementation tests and genotyping. Heterozygous polka mice were
crossed with homozygous sh14626SB mice, which carry a predicted
Myo7a-null allele (Mburu et al., 1997; Rinchik and Carpenter, 1999).
Auditory thresholds were determined by ABR tests. Genotyping was per-
formed by PCR using a set of primers that flank the polka mutation in the
Myo7a gene: forward primer, 535f 5-GGTCTTGCAGAAGTTGAGTG-
3, and reverse primer 535r 5-AAGCTTTGCTGCCATGTACC-3. PCR
fragments were purified and digested with BstYI to give a 150 bp product
in homozygous mutants, and 300 bp and 150 bp products in heterozy-
gous littermates. For the Myo7a4626SB mutation genotyping was per-
formed as described previously (Holme and Steel, 2002).
RT-PCR and quantitative PCR. RNA was isolated from cochleas and
eyes by using Trizol (Invitrogen), according to the manufacturer’s in-
structions. RNA concentration was determined using Nanodrop. cDNA
was synthesized from 400 ng of RNA with Superscript III reverse tran-
scriptase (Invitrogen) and oligo(dT) primers. RT-PCR analysis for the
splicing of Myo7a transcripts was performed with primers exon41f
5-CATAAGACTACCCAGATCTTC-3, exon42f 5-GGCTGCTGCT-
CAAGTCTTC-3, exon42r 5-GAAGACTTGAGCAGCAGCC-3, and
exon43r 5-GAAATCATTCTCTGGGACGC-3. Gene expression was
assessed by quantitative PCR by using gene-specific primers and SYBR
green (Applied Biosystems) in a PTC-200 thermal cycler (Bio-Rad) cou-
pled to a Chromo4 real-time PCR detection system (Bio-Rad). Myo7a
mRNA expression data were normalized by using cadherin 23 (Cdh23)
and otoferlin (Otof ), as well as the housekeeping genes 36B4 and GAPDH,
as reference genes. The primer sequences recognizing Myo7a were as
follows: forward primer, myo7a_5431f1 5-ATCCTCCTGCCTCATGT-
TCAG-3, reverse primer, myo7a_5594r1 5-CGGGGAAGTAGACCTT-
Figure 1. Auditory function in polka mice. A, Auditory brainstem response (ABR). Representative examples of click-evoked ABR
waveforms for a C57BL/6J wild-type and a polka homozygous mutant mouse at different sound intensities (in decibels). ABR waves
I–IV are indicated for recordings obtained from a wild-type mouse. The polka mutant mouse failed to respond to all tested sound
intensities (0 –90 dB). B, Average auditory thresholds for 2-month-old mice (wild type n  4, polka n  9; the mean  SD).
C, Representative DPOAE response spectra for a wild-type (top trace) and a polka mouse (bottom trace) at a single stimulus
condition (median primary frequency  16 kHz). Note the cubic distortion product (2f1  f2), which is absent in recordings with
polka mice at 60 dB. D, Cubic distortion product levels as a function of stimulus intensity at 10 kHz from wild-type and polka mice.
No response was observed in polka mice at all intensity levels (wild type n  4, polka n  9; mean  SD). E, DPOAE thresholds
were highly elevated at all frequencies analyzed (wild type n4, polka n9; meanSD). Primary frequencies were maintained
at an f2/f1 ratio of 1.22, and L1 was equal to L2.
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GTGGA-3; for cadherin 23: forward primer,
cdh23_6157f3 5-GCCCACCTGTTCATCA-
CTATC-3, reverse primer, cdh23_6260r3
5-TGGCTGTGACTTGAAGGACTG-3; for
otoferlin: forward primer, otof_4059f3 5-
GGAAGAGAAGGAAGAGATGGAAAG-3,
reverse primer, otof_4143r3 5-GGGCTCT-
GGTTTTTCTTCTTTTTC-3.
Results
Analysis of auditory and vestibular
function in polka mice
We have previously described a forward
genetics screen in mice aimed at identify-
ing recessive deafness traits (Schwander et
al., 2007). One of the lines from the
screen, termed polka, showed prominent
circling behavior and performed poorly in
forced swim tests, indicative of vestibular
dysfunction. Polka mice also failed to
show an acoustic startle response (ASR)
(Schwander et al., 2007). As defects in the
ASR can be caused by auditory defects,
general defects in the nervous system or
altered motor function, we next tested
polka mice for auditory function by eval-
uating their ABR (Zheng et al., 1999). To
determine auditory thresholds we applied
broadband click stimuli to 2-month-old
mice starting at 90 dB and then decreasing
in intensity. In polka mice ABR thresholds
were highly elevated (90 dB) when com-
pared to wild-type C57BL/6J mice (Fig.
1A,B), suggesting that the auditory phe-
notype can be attributed to impaired hair
cell or neuronal function. To study hair
cell function, we measured the DPOAEs.
In wild-type mice, DPOAEs were depen-
dent on the stimulus intensity at a given
frequency, but were not detectable in the
mutants, as shown in a plot of DPOAE
level versus stimulus level at the mean pri-
mary frequency of 10 kHz (Fig. 1C, D).
Similar observations were made at all of
the frequencies analyzed (6 –28 kHz) (Fig.
1E), indicating that the function of outer
hair cells was impaired across the entire
analyzed frequency spectrum.
Polka is a novel allele of the Myo7a gene
As part of the original genetic screen we performed heritability
testing and demonstrated that polka mice, which were derived on
a C57BL/6J background, inherit their deafness/balance pheno-
type recessively (Schwander et al., 2007). To map and positionally
clone the affected gene, we outcrossed affected polka mice to
129S1/SvImJ mice. The resulting offspring was intercrossed to ob-
tain F2 mice for ABR phenotyping, tail DNA preparation, and
SNP mapping. Consistent with a nonlethal recessive trait, we
found 21% of 190 F2 animals analyzed to be affected (Schwan-
der et al., 2007).
Using tail DNA from nine affected and four unaffected F2
animals (26 meiotic events), we ran SNP arrays as previously
described (Wiltshire et al., 2003; Schwander et al., 2007). The
mutation in polka mice mapped to a 27 MB interval on chromo-
some 7 (Fig. 2A). We next sequenced the exons and exon–intron
boundaries of all annotated and predicted genes in the interval,
including the Myo7a gene, which has previously been linked to
deafness in mice and humans (Gibson et al., 1995; Weil et al.,
1995). Sequencing of all exons of Myo7a from multiple affected
and unaffected control mice did not reveal any point mutations.
However, a G-to-A transition (c.5742  5G  A, reference se-
quence: NM_008663) was present at the fifth position of intron
42, and uniquely homozygous in mice that displayed the deafness
phenotype (Fig. 2B) (112 mice analyzed). The point mutation
was confirmed by restriction analysis (Fig. 2B,C). No mutation
was found in any other gene in the interval (data not shown).
To confirm that the point mutation in the Myo7a gene caused
the deafness phenotype, we performed complementation tests
with shaker-1 mice (sh14626SB) (Fig. 2D) (Rinchik et al., 1990;
Rinchik and Carpenter, 1999). The Myo7a4626SB mutation intro-
Figure 2. SNP mapping of the mutation in polka mice. A, DNA from nine affected mice (af) and four unaffected mice (uf)
was analyzed for SNP markers on chromosome 7, which are listed in the first column and indicate the megabase position
(68.363–103.844). The mouse identification numbers and phenotypes are indicated in the two top rows. The genotype for
each marker is given as follows: B, homozygous C57BL/6J genotype; C, homozygous BALB/cByJ; H, heterozygous; and
blanks indicate SNPs for which the data collection was incomplete. On the right is a diagram of mouse chromosome 7
showing the interval to which the auditory/vestibular phenotype mapped with the relative locations of three genes
reported within the interval. B, Sequence chromatograph from representative unaffected (wt) and affected (polka /)
mice at the 3-end of exon 42 of Myo7a. A G-to-A transition (c.5742  5G  A) that was found only in affected mice is
boxed. The point mutation creates a BstYI restriction site, facilitating genotyping of the mice. C, An agarose gel picture
shows the resolved fragments from BstYI RFLP/PCR analysis on genomic DNA of a wild-type, and a homozygous polka
mouse (wild type, 300 bp; and mutant, 150 bp). D, Complementation analysis. Homozygous polka mice were crossed with
heterozygous sh14626SB mice. Note that in the offspring only mice that were compound heterozygotes for the polka and
sh14626SB alleles showed elevated auditory thresholds.
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duces a stop codon near the 5 end, which likely results in a
functional null allele (Hasson et al., 1997; Mburu et al., 1997). We
crossed homozygous polka mice with heterozygous sh14626SB mice,
genotyped the offspring, and determined auditory thresholds by
measuring ABRs. Mice that were compound heterozygotes for
the polka and sh14626SB alleles tested deaf, while littermates carry-
ing one polka allele and one wild-type allele showed normal au-
ditory thresholds (Fig. 2D). Heterozygous sh14626SB mice also had
normal hearing function (data not shown). We conclude that the
point mutation in the Myo7a gene is responsible for the deafness
phenotype in polka mice.
The polka mutation affects splicing of the Myo7a transcript
The G-to-A transition in Myo7a disrupts the 3 end of the U1
snRNP binding site (Fig. 3A) (Blencowe, 2000). Applying the
statistical Shapiro–Senapathy splicing algorithm (Senapathy et
al., 1990), splice scores of 0.82 and 0.88 result for the mutant and
the wild-type variant, respectively. The lower splice score indi-
cates a lowered binding affinity of the mutated splice site with the
corresponding U1 snRNP, which could result in either exon skip-
ping or cryptic splice site activation (Krawczak et al., 2007). To
examine the effect of the mutation on the splicing of Myo7a tran-
scripts, we performed reverse-transcription PCR (RT-PCR) am-
plification on total RNA isolated from vestibular sensory patches
from wild-type and polka mice. Amplification with primers tar-
geting exon 42 and 43, which are located 5 and 3 of the mutated
intron 42, identified a novel Myo7a mRNA species in mutant
samples, which was 50 bp larger than the wild-type transcript
(Fig. 3B). Subcloning and DNA sequencing of the amplified
products revealed a 49 bp insert between exons 42 and 43 in polka
mice (Fig. 3C). The sequence of the insert completely matched
part of intron 42 indicating that the mutation in polka mice led to
the utilization of a cryptic splice site in
intron 42 (GA/GTGGGT) generating an
altered transcript (Myo7a42 49) that in-
cludes intronic sequences. The MYO7A
C-terminal tail contains two FERM do-
mains (Fig. 3D) (Chen et al., 1996). Based
on our sequencing data we predicted that
the polka mutation leads to premature
truncation of MYO7A after the first 56 aa
of the C-terminal FERM domain (re-
ferred to in the following as FERM2) and
the addition of a 33-aa-long aberrant
C-terminal peptide (Fig. 3D).
Defective hair bundle morphology and
melanosome localization in polka mice
Myo7a mutations in shaker-1 mice lead to
defects in hair bundle development in the
inner ear and to defects in the localization
of melanosomes to the apical process of
RPE (Liu et al., 1998; Self et al., 1998). To
determine whether the polka mutation
caused similar phenotypic defects, we first
stained cochlear sensory epithelia from
heterozygous and homozygous polka
mice as whole mounts with phalloidin to
label F-actin in stereocilia (Fig. 4). In
polka mice, stereociliary bundles were dis-
organized in all four rows of hair cells.
Fragmented bundles with defective mor-
phology were present that contained a
small number of short stereocilia (Fig. 4A,B, arrows), and some
bundles failed to develop a clear polarity in the apical hair cell
surface (Fig. 4B, asterisk). These findings were confirmed by
scanning electron microscopy (Fig. 4C–H). Bundles were
smaller, many of the stereocilia were short and malformed (Fig.
4D,H, arrows), and polarity defects were evident (Fig. 4D,H,
asterisk).
Next we analyzed retinal sections from polka mice (Fig. 5).
At the light microscopic level, 2-month-old polka mice re-
vealed no obvious structural defects in the retina, including
the photoreceptors. However, unlike in wild-type mice, mela-
nosomes did not localize to the apical processes of RPE cells
(Fig. 5B, arrowheads). We conclude that the polka mutation
leads to similar phenotypic manifestations in the ear and ret-
ina as observed in shaker-1 mice.
MYO7A expression is affected in a tissue-specific manner
Several shaker-1 mutations map to the myosin motor domain
and are thought to affect both motor function and MYO7A pro-
tein levels (Hasson et al., 1997; Mburu et al., 1997). As the muta-
tion in polka mice maps to the tail domain, we hypothesized that
it might affect hair cells and RPE cells by a different mechanism.
As one possibility, truncation of the FERM2 domain might affect
protein function in cargo transport. However, the mutation
might also lead to instability of the RNA or protein thereby af-
fecting MYO7A levels. To distinguish between these possibilities,
we compared the expression of the MYO7A transcript and pro-
tein in wild-type and polka mice.
Murine MYO7A is a 250 kDa polypeptide that is highly ex-
pressed in the cochlea, retina, testis, lung, and kidney (Hasson et
al., 1995). To analyze MYO7A protein expression, we performed
Western blots on tissue extracts from wild-type and mutant mice
Figure 3. RT-PCR analysis of mRNA from the Myo7a locus. A, Predicted donor splice site motif and splice score. B, RT-PCR
analysis of the Myo7a transcripts obtained from the inner ear (P5) from wild-type and polka mice. PCR analysis of genomic
DNA from wild-type mice was included as a control. Note that fragments including the polka mutation (Ex42/43, Ex41/43)
were 50 bp larger than fragments amplified from wild-type mRNA. C, Sequence determination of Myo7a PCR products
generated from mutant mice. A splicing defect induced the retention of the first 49 bp of intron 42. D, Domain structure of
MYO7A. The polka mutation creates a frameshift and introduces a premature stop codon, which is predicted to truncate the
protein within the FERM2 domain.
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(Fig. 6A). A 250 kDa protein was detected in extracts from brain,
kidney, eye and ear in wild-type mice. In eye and brain extracts of
homozygous mutant mice, the band for MYO7A was of similar
intensity as in wild type, but it was shifted to a slightly smaller size.
In eye extracts from heterozygous mutants two bands of the pre-
dicted size of full-length and mutant MYO7A could be distin-
guished (Fig. 6B). These findings support the interpretation of
our sequencing results, and indicate that as a consequence of
aberrant splicing a truncated MYO7A protein is expressed in the
brain and eye of polka mice. Quantification of expression levels
using Western blots from eye extracts confirmed that MYO7A
expression levels in the retina were not reduced (Fig. 6C). In
contrast, MYO7A expression levels were strongly reduced in ex-
tracts from mutant kidney and cochlea (Fig. 6A,C). We conclude
that the polka mutation leads to tissue-specific effects in the ex-
pression of MYO7A.
To further define the mechanisms that caused tissue-dependent
instability of mutant MYO7A, we compared mRNA levels of
Myo7a in eye and ear tissues from polka and wild-type mice by
quantitative RT-PCR analysis. Expression of Myo7a transcripts
Figure 6. MYO7A protein and mRNA expression. A, Western blot analysis revealed a
slightly reduced molecular weight for MYO7A in brain and eye extracts from mutant mice,
while its expression was drastically reduced in kidney and cochlea. B, Wild-type and
mutant MYO7A were detected as a double band in eye extracts from heterozygous polka
mice. An additional smaller band of unknown origin was identified only in extracts from
heterozygous mice (asterisk). C, Densitometry of Western blots. D–F, Real-time RT-PCR
analysis. mRNA levels of Myo7a in ear and eye were quantified in relation to otoferlin
(Otof) (D), 36B4 (E), and cadherin 23 (Cdh23) (F ). Levels of Myo7a were drastically de-
creased in ears, but not in eyes of polka mice. Data are expressed relative to levels of Myo7a
transcripts in wild type [set as equal to 1; mean  SEM of 4 animals ( polka) and 3 animals
(wild type) per group].
Figure 4. Analysis of hair bundle morphology. A, B, Images of phalloidin-stained whole
mounts from the middle turn of the cochlea of heterozygous (A) and homozygous (B) polka
mice at postnatal day 5 (P5). In polka mice morphological changes were evident such as splay-
ing of stereocilia (arrows) and cell polarity defects (asterisk). C–H, Scanning electron micro-
graphs of cochlear whole mounts of P5 heterozygous (C, E, G) and homozygous (D, F, H ) polka
mice. Note that hair bundles were smaller and fragmented in homozygous mutants (arrows).
Scale bars: A, B, 8 m; C, D, 5 m; E–H, 2 m.
Figure 5. Defects in melanosome localization. A, B, Retinal semithin sections from
6-month-old mice. Polka mice showed no signs of retinal degeneration (A). Melanosomes
failed to localize in apical processes of mutant RPE cells (B, arrowheads). OS, Photorecep-
tor outer segments; IS, photoreceptor inner segments; ONL, outer nuclear layer; OPL,
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; Scale bars: A, B,
10 m.
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was strongly decreased in ear tissue of mutant mice when com-
pared with wild type (Fig. 6D–F). In contrast, no significant
difference in the levels of Myo7a was observed in the eye (Fig.
6D–F), suggesting that mutant mRNAs in the ear but not the
retina are degraded by the nonsense-mediateddecaypathway(Isken
and Maquat, 2008).
Interestingly, while reduced levels of a
truncated MYO7A protein were still ex-
pressed in the inner ear of polka mice, the
protein was no longer detectable in stere-
ocilia (Fig. 7A,B), suggesting that the re-
sidual protein was confined to the cell
body. We next determined the expression
and localization of the truncated MYO7A
protein in the retina of polka mice by im-
munohistochemistry. At the light micro-
scopic level, MYO7A was still localized to
the apical processes of RPE cells, although
the signal appeared more diffuse and was
more widespread (Fig. 8A,B), indicative
of changes of MYO7A distribution within
RPE cells.
Previous studies have provided evi-
dence that the exophilin, Slac2-c/MYRIP,
binds to a domain in MYO7A that includes
the FERM2 domain, which is affected by
the polka mutation. Furthermore, Slac2-c/
MYRIP links RAB27A on melanosomes to
MYO7A (El-Amraoui et al., 2002; Fukuda
and Kuroda, 2002; Kuroda and Fukuda,
2005; Klomp et al., 2007). The functional
significance of these interactions has re-
mained unclear. We hypothesized that
these interactions might be important for
melanosome transport into the apical
processes of RPE cells, and that this pro-
cess might be affected in polka mice. We
therefore determined the subcellular dis-
tribution of MYO7A and Slac2-c/MYRIP in
RPEs by immunoelectron microscopy (Fig. 9). Quantification of
immunogold showed that total levels of MYO7A and MYRIP
were unaffected in RPE cells and in photoreceptor cilia of mutant
mice (Fig. 9; supplemental Fig. 1, available at www.jneurosci.org
as supplemental material; and data not shown), consistent with
the Western blot data. However, the fraction of MYO7A associ-
ated with melanosomes was significantly reduced in mutants
compared to wild type, and the number of melanosomes without
MYO7A was significantly increased. In parallel, MYO7A levels in
the apical region of RPE cells were reduced, and in the basal
region increased, indicating that MYO7A was redistributed in the
mutants. The data suggest that the FERM2 domain is required for
the recruitment of MYO7A to melanosomes (Fig. 9A, B, E). In
contrast, the density of Slac2-c/MYRIP on melanosomes was un-
affected (Fig. 9C–E). As Slac2-c/MYRIP also binds to the mela-
nosome associated protein RAB27A, our findings suggest that
Slac2-c/MYRIP is recruited independently of MYO7A to mela-
nosomes. However, disruption of the interaction between Slac2-
c/MYRIP and MYO7A likely explains the defect in the transport
of melanosomes into the apical processes of RPEs.
Discussion
We describe here the polka mouse line, which carries a point
mutation in Myo7a that sheds light on the function of its tail
domain. The polka mutation led to aberrant splicing of Myo7a
transcripts that affected its stability in the inner ear. As a conse-
quence, the MYO7A protein was no longer expressed in the
stereocilia of hair cells, leading to defects in hair bundle develop-
ment. In contrast, in the retina of polka mice MYO7A protein
with a truncation in the FERM2 domain were expressed at similar
Figure 7. MYO7A expression in hair cells. A, Cochlear whole mounts of heterozygous and homozygous polka mice at P5 were
stained with phalloidin (green) to reveal hair cell stereocilia and an antibody against MYO7A (red). MYO7A expression was detected
in outer and inner hair cells of heterozygous mice but was absent in the mutants. B, At higher magnification, MYO7A was localized
to the cuticular plate and toward tips of stereocilia in heterozygous mice. In mutant hair cells, MYO7A could no longer be detected.
Occasionally, very low amounts of protein could be visualized at tips of stereocilia in some hair cells (arrows). Scale bars: A, B, 8 m.
Figure 8. MYO7A expression in the retina. A, B, Retinal cryosections from wild-type and
polka mutant mice were stained with antibodies against MYO7A (red) and with phalloidin
(green) to visualize F-actin (A). In B, high-magnification views of stainings for MYO7A
(red) are shown. Expression of MYO7A in the apical RPE of polka mice was still detectable
but not as well confined to the apical region of the cells compared to wild type (B, arrows).
Scale bars: A, B, 10 m.
Schwander et al. • Myo7a and Hearing Loss J. Neurosci., December 16, 2009 • 29(50):15810 –15818 • 15815
levels as full-length protein in wild-type mice. As a consequence,
melanosome transport in RPE cells was affected. We conclude
that the FERM2 domain of MYO7A is required for cargo trans-
port into the apical processes of RPE cells. Our findings also show
that a Myo7a point mutation can differentially affect gene expres-
sion in the inner ear and retina. The latter findings might explain
why some mutations in MYO7A in humans only affect hearing
function, while others affect both hearing and vision.
Previous studies have provided insights into the mechanisms
by which mutations in Myo7a can cause disease, largely focusing
on different alleles of Myo7a that affect its motor domain. While
mRNA levels were not affected in mice carrying mutations in the
MYO7A motor domain, protein levels were drastically reduced,
leading to the suggestion that motor-domain mutations destabi-
lize MYO7A (Hasson et al., 1997). In addition, some USH1 mu-
tations in the MYO7A head domain also affect motor function of
recombinant human MYO7A, suggesting that defects in the in-
teraction of MYO7A with actin also contribute to the disease
(Watanabe et al., 2008).
Our findings now show that pathological changes in polka
mice are caused by different mechanisms. The mutation in
polka mice inactivates the exon 42 splice donor site in Myo7a
and activates a cryptic splice-donor within the intron flanked
by exon 42 and 43. Therefore a Myo7a transcript is generated
with a 49 base pair intronic insert that introduces a premature
stop codon. The abundance of the aberrantly spliced tran-
script is drastically reduced in the cochlea, likely as a conse-
quence of nonsense-mediated mRNA decay (Isken and
Maquat, 2008). MYO7A protein is also no longer detectable in
stereocilia leading to defects in hair bundle development. In
contrast, Myo7a transcripts escaped nonsense-mediated decay
in the retina leading to the expression of a truncated MYO7A
protein at similar levels as in wild-type mice. However, our
findings provide evidence that the truncated protein is func-
tionally impaired. Despite the presence of the truncated
MYO7A protein in the apical processes of RPE cells, polka
mice show defects in melanosome organization indistinguish-
able from the shaker-1 phenotype (Liu et al., 1998; Gibbs et al.,
2004).
Mutant MYO7A may be misfolded or compromised in its
motor function as studies with myosin V have shown that
the tail domain regulates the function of its motor domain
(Trybus et al., 1999; Homma et al., 2000; Wang et al., 2000;
Thirumurugan et al., 2006). However, we think that this pos-
sibility is unlikely because mutant MYO7A is properly tar-
geted to the apical processes of RPE, which would likely not
occur with a misfolded protein or a protein without motor
function. Instead, we favor the alternative hypothesis that
MYO7A is unable to bind and transport cargo. Consistent
with this model, the exophilin Slac2-c/MyRIP is thought to
function as a linker protein between RAB27A on melanosomes
and MYO7A (Fukuda and Kuroda, 2002; Kuroda and Fukuda,
2005; Klomp et al., 2007). In yeast two-hybrid and in in vitro
assays Slac2-c/MyRIP can bind to the C-terminal 464 aa of
MYO7A that contain the FERM2 domain (El-Amraoui et al.,
2002). Therefore, disruption of the FERM2 domain might affect
interactions with melanosomes, which is consistent with our im-
munoelectron microscopy studies that revealed reduced associa-
tion of MYO7A with melanosomes in RPEs of polka mice.
Interestingly, polka mice like previously described Myo7a al-
leles fail to show clear signs of retinal degeneration, highlighting
the fact that melanosome localization is not critical for retinal
viability (Liu et al., 1998). In fact, most, if not all mouse models of
USH1 do not reproduce the retinal degeneration phenotype of
USH1 patients (Williams, 2008). A recent study suggests that
defective photoreceptor function might cause retinal degenera-
tion in USH1B (Jacobson et al., 2008). The reason why genetic
lesions in polka and shaker-1 alleles do not reproduce the photo-
receptor degeneration found in USH1B patients remains ob-
scure. Possibilities have been discussed previously (Liu et al.,
1998; Lillo et al., 2003), but it should be noted that many mouse
models of retinal degeneration, as well as other neurodegenera-
tive disorders, mimic the pathological changes observed in hu-
mans only incompletely. Of interest, however, is the recent
demonstration that mutations in the FERM2 domain of MYO7A
can lead to USH1B in humans (Jaijo et al., 2006; Riazuddin et al.,
Figure 9. Subcellular localization of MYO7A and MYRIP in the RPE. A–D, Immunoelec-
tron microscopy on wild-type (A, C) and mutant (B, D) RPE from retinal sections labeled
with anti-MYO7A and anti-MYRIP antibody and 15 nm protein A– gold. Gold particles
have been circled. E, Quantification of the immunolocalization data. Gold particles were
counted in ultrathin sections. Twenty-five images were analyzed randomly for each con-
dition and animal. Gold particles were considered to be associated with the melanosome
membrane when located at a maximum of 30 nm from the membrane of the organelle, as
described previously (Klomp et al., 2007). Values are mean  SEM (n  3 wild-type and
mutant animals). Scale bar, 100 nm.
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2008). Similar to the allele identified in polka mice, the FERM2
mutation (c.5856G  A) affects the last nucleotide in exon 42 and
has been predicted to influence splicing of the myo7a transcript
(Jaijo et al., 2006). Based on our studies, it seems likely that such
mutations in the FERM2 domain destabilized the myo7a tran-
script in the inner ear thereby causing defects in hair bundle
development. In contrast, MYO7A protein in the retina might be
functionally impaired leading to visual defects in the affected
patients. As disease causing mutations have been mapped to sev-
eral structural domains within the complex MYO7A tail region, it
will be important to generate in the future mouse models that
specifically target other structural domains besides the FERM2
domain to define their function as well as pathogenesis mecha-
nisms that lead to visual and auditory impairment.
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